Voveran SR (Diclofenac Sustained-Release): Uses, Dosage, Safety and Interactions

Voveran SR is a sustained-release diclofenac product, an NSAID used to relieve pain and inflammation when a clinician judges that this formulation is suitable. Sustained-release tablets are designed to release diclofenac over a longer period; they are not interchangeable with immediate-release, delayed-release, topical, or injectable diclofenac products. Patients with a valid prescription may buy Voveran SR from a properly licensed pharmacy after the prescriber has chosen the correct formulation and assessed relevant risks. Voveran SR price may vary by tablet strength, pack quantity, pharmacy, and coverage, but it should never be used as a reason to alter the schedule or replace an SR product with another formulation on your own.

Diclofenac reduces prostaglandin production and can relieve symptoms such as pain, stiffness, and swelling. It does not cure arthritis or repair an injury. Treatment should be individualized, using the lowest effective dose for the shortest duration that meets the therapeutic goal. People with ongoing or worsening pain, severe injury, unexplained swelling, or systemic symptoms need clinical reassessment rather than simply taking more medicine.

Indications

Voveran SR may be prescribed for inflammatory pain and selected arthritic conditions, depending on the approved local product information. It may help reduce symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or other clinician-diagnosed inflammatory musculoskeletal conditions. It is not appropriate for every episode of pain and should not be used as a substitute for evaluation of chest pain, severe abdominal pain, new neurological symptoms, infection, or trauma.

Dosage

Take Voveran SR exactly as prescribed, with water and preferably with food if stomach upset occurs. Swallow sustained-release tablets whole; do not split, crush, chew, or dissolve them. Altering the tablet can release diclofenac too quickly and increase adverse effects. Do not use it more frequently than directed, and do not combine it with another diclofenac product, ibuprofen, naproxen, ketorolac, or other NSAIDs unless a clinician explicitly directs this.

Voveran SR strengths may include 75 mg or 100 mg depending on the country and product supply. Patients with a valid prescription can buy Voveran SR 75 mg when that strength and sustained-release formulation match the clinician’s regimen. Patients may buy Voveran SR 100 mg only after the pharmacist verifies the prescription and the prescriber’s intended daily schedule. Voveran SR price should be compared only for the same sustained-release strength and quantity; it is unsafe to substitute a non-SR tablet or to combine lower-strength tablets without professional instruction.

If a dose is missed, take it when remembered unless it is close to the next dose. Do not double up. Contact the prescriber if pain is not adequately controlled or if treatment is needed beyond the planned interval. An overdose needs urgent medical assessment even if symptoms are initially mild.

Safety Information

Diclofenac and other NSAIDs can increase the risk of serious cardiovascular events, including heart attack and stroke. This risk can occur early and may rise with longer use. Voveran SR is contraindicated for treatment of pain around coronary artery bypass graft surgery. Before treatment, tell the prescriber about coronary disease, prior heart attack or stroke, high blood pressure, heart failure, fluid retention, kidney disease, liver disease, ulcers, gastrointestinal bleeding, asthma, nasal polyps, smoking, diabetes, and prior allergy or asthma symptoms after aspirin or another NSAID.

Serious stomach or intestinal bleeding, ulceration, and perforation can occur without warning. Seek emergency care for black stools, blood in vomit, severe abdominal pain, fainting, chest pain, trouble breathing, weakness on one side, slurred speech, marked swelling, or very little urine. Stop the medicine and seek urgent advice for hives, facial or throat swelling, wheezing, fever with rash, blistering, or peeling skin. The risk can be higher in older adults and in people taking blood-thinning or steroid medicines.

Diclofenac can cause fetal harm. Avoid use from about 20 weeks of pregnancy unless specifically directed, and avoid use at about 30 weeks and later. Discuss pregnancy, conception plans, and breastfeeding with a clinician. Patients obtaining Voveran SR should use a pharmacy that verifies the SR formulation and checks for contraindications. Voveran SR price does not replace risk assessment or follow-up.

Interactions

Other NSAIDs and aspirin can increase gastrointestinal and bleeding risk. Anticoagulants, antiplatelet medicines, corticosteroids, SSRIs, and SNRIs may also increase bleeding risk. Diclofenac can affect lithium and digoxin levels. ACE inhibitors, angiotensin-receptor blockers, diuretics, and other medicines that affect kidney blood flow can raise the risk of kidney injury or reduce control of blood pressure, especially in people who are dehydrated or have kidney disease.

Methotrexate, cyclosporine, and alcohol require careful discussion with the prescriber or pharmacist. A valid prescription is required to buy Voveran SR, and the pharmacist should verify the sustained-release product before dispensing. Provide a complete list of prescription medicines, nonprescription products, supplements, and herbal products before starting Voveran SR. Do not start, stop, or change another medicine because of this page without professional guidance.

Medical disclaimer: This content is for informational purposes only and does not replace advice, diagnosis, or treatment from a licensed healthcare professional. It is not a substitute for the approved product information or emergency care. Patients should follow their prescriber’s directions and consult their healthcare professional about personal medical decisions, symptoms, medicines, and treatment changes.